Humoral and cellular responses to SARS-CoV-2 vaccines before and after chimeric antigen receptor-modified T-cell therapy.
Gonzalez MA, Bhatti AM, Fitzpatrick K, Boonyaratanakornkit J, Huang ML, Campbell VL, Hecht J, Ibrahimi S, Wanner SN, Green DJ, Maloney DG, Gauthier J, Cowan AJ, Greninger AL, Krantz EM, Koelle DM, Hill JA.
Gonzalez MA, et al. Among authors: bhatti am.
Blood Adv. 2023 May 9;7(9):1849-1853. doi: 10.1182/bloodadvances.2022008338.
Blood Adv. 2023.
PMID: 36094846
Free PMC article.
No abstract available.